MCAP MedCap AB (publ)

STO · SE · Financial Services · Medical Devices · medcap.se

510.00SEK-0.29%Mkt Cap: 732.70M $P/E: 31.73Today

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It pref…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.60BUSDP/E 18.7

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

Key Statistics

Company

Market Cap732.70M USD

Enterprise Value749.25M USD

Revenue (TTM)215.89M USD

Gross Profit118.24M USD

Net Income (TTM)21.02M USD

Revenue/Share150.71 SEK

Last Price510.00 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees647

CountrySE

SectorFinancial Services

IndustryMedical Devices

ISIN—

Valuation

P/E (Trailing)31.73

P/E (Forward)100.89

PEG—

EV/EBITDA18.26

EV/Revenue3.47

P/S3.39

P/B4.83

EPS (TTM)16.00

EPS (Forward)5.07

52W Range

440.0036% of range636.00

52W High636.00 SEK

52W Low440.00 SEK

Profitability

Gross Margin58.64%

Oper. Margin14.63%

EBITDA Margin19.00%

Profit Margin10.43%

ROE15.14%

ROA8.43%

Growth

Revenue Growth16.20%

Earnings Growth28.80%

Cash Flow & Leverage

Operating CF32.78M USD

CapEx (TTM)5.95M USD

FCF Margin14.98%

FCF Yield4.41%

Net Debt16.39M USD

Net Debt/EBITDA0.40

Balance Sheet

Debt/Equity0.33

Current Ratio1.86

Quick Ratio1.32

Book Value/Sh105.91 SEK

Cash/Share19.12 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 SEK

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:10

Split DateSep 27, 2016

Analyst Consensus

Rating—

Target (Mean)640.00 SEK

Upside (mean)+25.5%

Target Range620.00 SEK – 660.00 SEK

620.00+25.5% to mean660.00

# Analysts2

Ownership

Shares Out.14.98M

Float14.81M

Insiders20.91%

Institutions53.45%

Technical

SMA 50542.88 (-6.1%)

SMA 200514.44 (-0.9%)

Beta0.49

S&P 52W Chg14.58%

Avg Vol (30d)15.76K

Avg Vol (10d)21.65K

Technical Indicators

RSI (14)36.3

MACD-7.2139

MACD Signal-5.1733

MACD Hist.-2.0406

BB Upper550.25 SEK

BB Middle529.92 SEK

BB Lower509.60 SEK

BB Width7.67%

ATR (14)13.51 SEK

Vol Ratio (20d)3.26x